The Good Bug introduces a unique weight loss solution with clinically proven Natural GLP -1 amidst rising obesity rates in India

Natural weight loss solution with no side effects

Natural GLP -1 based on science, available at an affordable price of ₹2000 per month

New Delhi, April, 2025: India is facing a major health challenge and that is the increasing obesity rate across all age groups. This is leading to an alarming rise in early mortality rates related to diabetes, cardiovascular diseases and cancer. According to the National Family Health Survey (NFHS-5), approximately 24% of women and 22.9% of men are now obese.

The Good Bug, a leading gut health brand in India, has introduced a remarkable scientific innovation for weight loss. The Good Bug's Advanced Metabolic System Natural GLP -1 is the latest breakthrough in science that provides an affordable and science-backed solution to weight loss. This success has been scientifically validated, with clinical trial data showing a 12.01% weight loss, 9.64% smaller waist size, and 12.14% reduction in BMI over 90 days.

Keshav Biyani, Co-Founder, The Good Bug said, “Developed through cutting edge gut microbiome research, Advanced Metabolic System is a proprietary blend of clinically tested probiotics and prebiotics that reduce obesity through natural GLP-1 activation without the common side effects associated with weight loss drugs. With the launch of this product validated through scientific clinical trials, we are proud to introduce a first of its kind global innovative solution that delivers up to 12% weight loss in 90 days. As a pioneer in the gut health segment, we identified that the main cause of obesity is an imbalance in the gut biome composition. Years of R&D to create an effective solution that can ultimately help increase GLP-1 and GIP naturally for effective weight loss have led to this. This is a major scientific breakthrough for us that has been discovered, developed and manufactured in India. It will redefine the process of weight loss globally.

Pharmaceutical Unlike GLP-1 agonists, which are often associated with side effects and addiction, The Good Bug’s advanced metabolic system naturally increases GLP-1 levels in the body, reducing chronic inflammation in the gut, thereby controlling appetite and reducing cravings to deliver lasting weight and health results. Trusted by healthcare professionals, this product offers an affordable and natural approach to weight loss. The Good Bug plans to take the product to global markets including the US.

Dr. M.K.N., Senior Consultant, Manipal Hospitals and Principal Investigator of the trial said, Manohar said, “In clinical trials, the results were not only statistically significant, but also clinically meaningful. It is comparable to the best drugs available till date. What was evident in the trials was a spontaneous decrease in food cravings and increased satiety. More than 90% of the people reported a reduction in their cravings for food; 95% reported suppression of appetite. This mirrors what is seen with synthetic GLP-1 drugs. Importantly, there were no major adverse events. And the trials showed clear improvements in appetite, satiety and energy levels.”

He added, “Obesity has become a silent epidemic, which has been exacerbated by COVID. There is a huge disconnect between lifestyle changes and treatments like surgery. Scientific evidence is increasingly pointing to the gut microbiome as the cornerstone of metabolic health and affordable weight management. Synthetic interventions often come with side effects, but a research-based probiotic formulation like The Good Bug leverages the natural synergy between gut bacteria and the body’s metabolism.”

Available at just ₹2000 per month or ₹5000 for three months, The Good Bug’s solution is available across online platforms and retail stores. The Good Bug is redefining the role of gut health in overall wellness by focusing on research-based efficacy and transparency.

Prabhu Karthikeyan, Co-Founder, The Good Bug said, “We understand the impact of microbiome science not only on digestive health but also on metabolic health, women’s health and cognitive well-being. As research on the microbiome grows, it brings forth a new dimension to healthcare and we are committed to harnessing its potential. We continuously strive to create consumer health solutions through advanced probiotic innovation and empower people to take control of their health through science-based products. We are eager to see how this new launch changes the obesity scenario in the country.”

Obesity has emerged as a major problem and in view of this emerging scenario, the Hon’ble Prime Minister, Shri Narendra Modiji has recently launched an anti-obesity campaign. According to data from the Indian Council of Medical Research (ICMR), over 180 million Indians were classified as overweight or obese in 2021, but recent studies suggest this number could rise to 400 million by 2050. This further highlights the urgent need for effective, clinically proven and affordable solutions like The Good Bug.